The emergence of new therapeutic agents such as Aducanumab, Lecanemab, and Donanemab for Alzheimer’s disease (AD) offers promising prospects for managing this debilitating condition.

2 weeks ago 8
The emergence of new therapeutic agents such as Aducanumab, Lecanemab, and Donanemab for Alzheimer’s disease (AD) offers promising prospects for managing this debilitating condition. submitted by /u/ashokar141
[link] [comments]
Read Entire Article